Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Study to Evaluate Safety and Efficacy of Ologen® Collagen Matrix in Patients With Primary Congenital Glaucoma Undergoing Trabeculectomy

NCT03541551 is registered in ClinicalTrials.gov with L.V. Prasad Eye Institute as lead sponsor.

NCT NCT03541551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03541551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Study to Evaluate Safety and Efficacy of Ologen® Collagen Matrix in Patients With Primary Congenital Glaucoma Undergoing Trabeculectomy
Lead sponsor
L.V. Prasad Eye Institute
Phase
Not applicable
Overall status
Completed
Start date
July 13, 2018
Completion date
September 1, 2019
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

developmental glaucoma, infantile glaucoma, primary congenital glaucoma